Results 4,201-4,220 of 14,090 for speaker:Marc MacSharry

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Yes.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: I will be as quick as I can. What is the €25 million per year for?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Sorry. Was there not some-----

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: It costs €30 million to run the show.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: What is the cost of the tribunal itself?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: That is the total cost, but I am asking about the annual cost. Obviously, there are legal and administration people in place.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Over the 20 years, have we streamlined the process? Have we been able to reduce administrative or legal costs or has it been a one-way trajectory upwards?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Does anyone?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Does anyone have a role in overseeing that and ensuring that everything is-----

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: I understand that, and I get that Mr. Breslin is not responsible.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Does the Comptroller and Auditor General have any role in this?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: I read those, so I will not hold up the meeting by asking the Comptroller and Auditor General to go through them. I am interested in knowing whether the Comptroller and Auditor General audits the tribunal.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Have the costs increased?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: They are pretty static. Have they decreased through efficiencies or a diminishing number of claimants?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Have the legal and administrative costs increased or remained static?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Other tribunals' costs decreased a bit, but then certain heads of tribunals asked that they be increased again. Was this tribunal one of those?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: Its costs decreased.

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: There was an agreement that we would cut them all. Individual tribunals were saying that we needed more money and that was acceded to in some instances. Was this an example?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: It would be good practice when something has been going on for so long and will continue. Where are we with the legal spending?

Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 15: Hepatitis C Treatment in Ireland
Management of Medical Negligence (22 Nov 2018)

Marc MacSharry: That would be good.